Navellier & Associates Inc. Purchases Shares of 30,107 Alignment Healthcare, Inc. $ALHC

Navellier & Associates Inc. purchased a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 30,107 shares of the company’s stock, valued at approximately $525,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ALHC. SBI Securities Co. Ltd. increased its position in Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after acquiring an additional 2,970 shares during the period. KBC Group NV bought a new position in shares of Alignment Healthcare in the second quarter worth $44,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Alignment Healthcare during the third quarter valued at about $53,000. Ameritas Investment Partners Inc. raised its stake in shares of Alignment Healthcare by 32.9% during the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock valued at $182,000 after purchasing an additional 3,225 shares in the last quarter. Finally, State of Alaska Department of Revenue acquired a new stake in Alignment Healthcare in the third quarter worth about $186,000. 86.19% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research note on Friday, January 30th. Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. UBS Group raised their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Finally, KeyCorp reiterated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $23.32.

Alignment Healthcare Trading Down 1.2%

Shares of NASDAQ:ALHC opened at $20.39 on Thursday. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of -169.92, a PEG ratio of 5.26 and a beta of 1.16. Alignment Healthcare, Inc. has a 1-year low of $11.63 and a 1-year high of $23.87. The company has a 50 day moving average price of $20.88 and a 200 day moving average price of $17.98.

Insider Buying and Selling

In related news, insider Robert L. Scavo sold 69,541 shares of Alignment Healthcare stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $1,303,198.34. Following the transaction, the insider owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. This trade represents a 12.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Dawn Christine Maroney sold 282,070 shares of the business’s stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80. Following the sale, the president owned 1,385,167 shares in the company, valued at approximately $25,958,029.58. The trade was a 16.92% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 2,120,938 shares of company stock worth $41,655,670 in the last three months. 7.00% of the stock is currently owned by insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.